+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

H1N1 Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

  • ID: 4775631
  • Report
  • June 2019
  • Region: Global
  • 85 pages
  • IMARC Group
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now
The global H1N1 vaccines market is currently exhibiting strong growth. The H1N1 virus, commonly known as swine flu is an infectious disease characterized by a persistent cough, high fever, red-watery eyes, body aches and headache. The illness is known to have a detrimental effect on the existing chronic ailments, such as Pneumonia, Chronic Obstructive Pulmonary Disease (COPD) and Bronchitis, and can be fatal in severe cases. H1N1 vaccines are a preventive measure administered through intradermal and intranasal procedures to provide active immunization against the virus.

Increasing incidences of epidemic H1N1 infection and declining immunity of the general population are among the key factors driving the market growth. With increasing age, the risk of developing respiratory tract diseases and immunodeficiency disorders also escalates, thereby increasing the risk of acquiring the swine flu infection. However, extensive research and development in the field of immunology and vaccine technologies coupled with extensive support from global health organizations are expected to promote the distribution of quality vaccines. Moreover, a number of developed countries such as Australia, the United Kingdom, and the United States have also included H1N1 vaccinations under their National Immunization Program (NIP) that has increased the demand for these vaccines. Additionally, technological advancements coupled with a rising awareness amongst patients about preventive methods has also led to a heightened demand for H1N1 vaccines.

This latest report provides a deep insight into the global H1N1 vaccines market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global H1N1 vaccines market in any manner.

Report Coverage:

Historical, Current and Future Market Trends

Breakup by Vaccine Type
Intramuscular
Intranasal
Intradermal

Breakup by Market Type:
Public
Private

Analysis of Key Brands:
Agripal
Fiuarix
Influgen
Influvac
Nasovac
Vaxigrip
Others

Breakup by Region:
North America
Europe
Asia Pacific
Middle East and Africa
Latin America

Competitive Landscape:

The report has also analysed the competitive landscape of the market along with the profiles of the key players.

Key Questions Answered in This Report:

How has the global H1N1 vaccines market performed so far and how will it perform in the coming years?
What are the key regional markets in the global H1N1 vaccines industry?
What is the breakup of the market based on the vaccines type?
What is the breakup of the market based on the market type?
What are the various stages in the value chain of the global H1N1 vaccines industry?
What are the key driving factors and challenges in the global H1N1 vaccines industry?
What is the structure of the global H1N1 vaccines industry and who are the key players?
What is the degree of competition in the global H1N1 vaccines industry?
What are the profit margins in the global H1N1 vaccines industry?
Note: Product cover images may vary from those shown
2 of 3
1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global H1N1 Vaccines Market
5.1 Market Overview
5.2 Market Performance
5.3 Breakup by Vaccines Type
5.4 Breakup by Market Type
5.5 Analysis of Key Brands
5.6 Breakup by Region
5.7 Market Forecast

6 Market Breakup by Vaccines Type
6.1 Intramuscular
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Intranasal
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Intradermal
6.3.1 Market Trends
6.3.2 Market Forecast

7 Market Breakup by Type
7.1 Public
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Private
7.2.1 Market Trends
7.2.2 Market Forecast

8 Market Breakup by Region
8.1 North America
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Europe
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Asia Pacific
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Middle East and Africa
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Latin America
8.5.1 Market Trends
8.5.2 Market Forecast

9 Analysis Of Key Brand
9.1 Agripal
9.2 Fiuarix
9.3 Influgen
9.4 Influvac
9.5 Nasovac
9.6 Vaxigrip
9.7 Others

10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis
13.1 Price Indicators
13.2 Price Structure
13.3 Margin Analysis

14 Industry Developments
14.1 Pipeline and New Product Launches
14.2 Mergers & Acquisitions and Partnerships

15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3

Loading
LOADING...

Adroll
adroll